요 약
인체 면역증강제로 활용 가능성을 조사하기 위해 R. aquatilis AY2000 균이 생산하는 당단백질인 AYS의 면역세포에 대한 독성과 면역증강 효과를 조사하였다. 그 결과 AYS는 적혈구에 대한 용혈작용과 hPBMC에 대한 증식 또는 사멸효과는 나타내지 않았으나, 배양 중인 hPBMC를 응집시키는 효과를 나타내었다. 또한 AYS는 in vitro에서 hPBMC에 작용하여 염증성 cytokine인 IL-6, IFN-γ, TNF-α와 IL-5 생성을 유도하였고, 생쥐에서 AYS는 alum에 비해 항-BSA의 생산력을 더욱 증가시켰다.
참고문헌
- Alan J, Robin T. 1982. Immunochemistry in practice. pp. 257-260. 2nd Ed. Blackwell Scientific Publications, London.
- Alexander BD, Erik BL, Ernesto OO. 2011. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol. Lett. 203: 97-105. https://doi.org/10.1016/j.toxlet.2011.03.001
- Ciapetti G, Cenni E, Pratelli L, Pizzoferrato A. 1993. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials 14: 359-364. https://doi.org/10.1016/0142-9612(93)90055-7
- Higgins D, Marshall JD, Traquinia P, Van Nest G, Livingston BD. 2007. Immunostimulatory DNA as a vaccine adjuvant. Expert. Rev. Vaccines 6: 747-759. https://doi.org/10.1586/14760584.6.5.747
- Khajuria A, Gupta A, Malik F, Singh S, Singh J, Gupta BD, et al. 2007. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 25: 4586-4594. https://doi.org/10.1016/j.vaccine.2007.03.051
- Lingnau K, Riedl K, von Gabain A. 2007. IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems. Expert Rev. Vaccines 6: 741-746. https://doi.org/10.1586/14760584.6.5.741
- Mbow ML, de Gregorio E, Ulmer JB. 2011. Alum's adjuvant action: grease is the word. Nat. Med. 17: 415-416. https://doi.org/10.1038/nm0411-415
- Muller BW, Bock T. 1994. A novel assay to determine the hemolytic activity of drug incorporated in colloidal carriers systems. Pharm. Res. 11: 589-591. https://doi.org/10.1023/A:1018987120738
- O'Hagan DT, Ott GS, de Gregorio E, Seubert A. 2012. The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine 30: 4341. https://doi.org/10.1016/j.vaccine.2011.09.061
- Park HJ, Kang MJ, Lee JH, Kim KH. 2011. Action pattern of anti-yeast substance originated from Rhanella aquatilis strain AY2000. Korean J. Microbiol. 47: 163-166.
- Schijns VE, Lavelle EC. 2011. Trends in vaccine adjuvants. Expert. Rev. Vaccines 10: 539. https://doi.org/10.1586/erv.11.21
- Tomljenovic L, Shaw CA. 2012. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatiric populations. Lupus 21: 223-230. https://doi.org/10.1177/0961203311430221
- Wang W, Singh M. 2011. Selection of adjuvants for enhanced vaccine potency. World J. Vaccines 1: 33-78. https://doi.org/10.4236/wjv.2011.12007